SMIM1

Chr 1AR

small integral membrane protein 1 (Vel blood group)

Also known as: Vel

This protein regulates red blood cell formation and serves as the antigen for the Vel blood group system. Autosomal recessive mutations cause Vel-negative blood group status, which can lead to hemolytic transfusion reactions and hemolytic disease of the newborn when Vel-negative individuals are exposed to Vel-positive blood. The gene shows low constraint to loss-of-function variation in the general population.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

[Blood group, Vel system]MIM #615264
AR
0
Active trials
2
Pubs (1 yr)
92
P/LP submissions
P/LP missense
1.82
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySMIM1
Population Constraint (gnomAD)
Low constraint (pLI 0.03) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
87 unique Pathogenic / Likely Pathogenic· 19 VUS of 112 total submissions
Some data sources returned errors (1)

pubtator: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.82LOEUF
pLI 0.033
Z-score 0.29
OE 0.80 (0.311.82)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.83Z-score
OE missense 0.66 (0.490.89)
31 obs / 46.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.80 (0.311.82)
00.351.4
Missense OE0.66 (0.490.89)
00.61.4
Synonymous OE0.85
01.21.6
LoF obs/exp: 2 / 2.5Missense obs/exp: 31 / 46.9Syn Z: 0.53
DN
0.7228th %ile
GOF
0.6832th %ile
LOF
0.3260th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

112 submitted variants in ClinVar

Classification Summary

Pathogenic85
Likely Pathogenic2
VUS19
Likely Benign2
Benign1
85
Pathogenic
2
Likely Pathogenic
19
VUS
2
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
85
Likely Pathogenic
2
VUS
19
Likely Benign
2
Benign
1
Total109

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SMIM1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →